Virus News and Research

Latest Virus News and Research

Identifying high-risk groups for COVID-19 in India

A new study from the Center for Disease Dynamics, Economics and Policy sets out indicators that identify the populations at the highest risk for COVID-19 in India. The study appears on the preprint website medRxiv in April 2020.

30 Apr 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer.

30 Apr 2020

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a "magic bullet" to prevent and cure COVID-19. And the medicines can - if used rashly - have serious side effects.

30 Apr 2020

KHN’s ‘What the Health?’: SCOTUS decides an ACA case. No, not that case.

The Supreme Court this week rejected the efforts of a Republican-controlled Congress in 2014 to cut off funding to insurance companies under a provision of the Affordable Care Act.

30 Apr 2020

Scientists generate molecular models of compounds relevant for COVID-19

The discovery of suitable drugs that could help treat diseases is a long process. However, computer-aided drug design and simulation could speed up the process and also increase the possibilities say experts. This form of drug design and simulation could soon be the gold standard in drug development.

30 Apr 2020

New database catalogs peptides that may halt SARS-CoV-2 cell infection

In the quest for a highly specific and tailored treatment strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent publication available on the preprint server bioRxiv describes a repository of designed peptides that interfere with the early stages of viral invasion process.

30 Apr 2020

Testing sewage could be useful in monitoring COVID-19 circulation in the population

Researchers in Italy have demonstrated the potential value of sewage system monitoring for studying trends in the circulation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

30 Apr 2020

TH Group gave one million glasses of fresh milk to Vietnamese people quarantined due to COVID-19

The Vietnamese Fatherland Front and TH Group – a leading dairy producer in Vietnam - announced a program on giving fresh milk produced by the group to nurses, doctors, and those who are in isolation due to COVID-19 in Vietnam.

30 Apr 2020

Researchers test clinical safety of gene-based treatment for achromatopsia

People with complete color blindness are born unable to distinguish colors. They see less sharply and are highly sensitivity to glare.

30 Apr 2020

UK-based biotechnology firm discovers potential treatments for Covid-19

A UK-based biotechnology firm has announced the discovery of two separate novel treatments for Covid-19 patients before they are put on ventilators. They are now urgently seeking funding of £4m to accelerate safety studies and clinical trials.

30 Apr 2020

Equating COVID-19 with high altitude pulmonary edema can have dangerous implications

Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE.

30 Apr 2020

Fear of coronavirus propels some smokers to quit

In 40 years of smoking, Katie Kennedy has tried four times to quit but always went back to cigarettes. Today, she is summoning a new mental image when a craving comes on: rows of COVID-19 patients hooked to ventilators.

30 Apr 2020

Newly launched clinical trial can help treat COVID-19 patients

Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.

30 Apr 2020

New rapid-release gas treatment for ambulances could remove Covid-19 contamination

Researchers from the university are helping slash the time it takes to clean an ambulance from 45 minutes to under 20 minutes.

30 Apr 2020

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.

30 Apr 2020

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

Remdesivir is an antiviral first developed by Gilead in 2014 as a treatment for Ebola and Marburg viruses. However, scientists explored its possibilities as a broad-spectrum drug when it proved effective against SARS-CoV and MERS-CoV, coronaviruses which were responsible for earlier outbreaks.

30 Apr 2020

A new model for identifying the most effective treatments for respiratory viral infection

When a person contracts a respiratory viral infection like COVID-19 or influenza, the immune system responds in a myriad of ways to eliminate the virus.

29 Apr 2020

Online searches for unproven therapies for COVID-19

A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.

29 Apr 2020

Antibody produced by llamas shows promise against SARS-CoV-2

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.

29 Apr 2020

Virus News and Research

Latest Virus News and Research

Identifying high-risk groups for COVID-19 in India

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

KHN’s ‘What the Health?’: SCOTUS decides an ACA case. No, not that case.

Scientists generate molecular models of compounds relevant for COVID-19

New database catalogs peptides that may halt SARS-CoV-2 cell infection

Testing sewage could be useful in monitoring COVID-19 circulation in the population

TH Group gave one million glasses of fresh milk to Vietnamese people quarantined due to COVID-19

Researchers test clinical safety of gene-based treatment for achromatopsia

UK-based biotechnology firm discovers potential treatments for Covid-19

Equating COVID-19 with high altitude pulmonary edema can have dangerous implications

Fear of coronavirus propels some smokers to quit

Newly launched clinical trial can help treat COVID-19 patients

New rapid-release gas treatment for ambulances could remove Covid-19 contamination

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

A new model for identifying the most effective treatments for respiratory viral infection

Online searches for unproven therapies for COVID-19

Antibody produced by llamas shows promise against SARS-CoV-2

A new way of characterising biomolecules eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in